Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Levin

Showing results (121-130 of 217) with videos related to

Pageof 22
Sort By:
Leukemia|April 26, 2023
Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translationKaroline Kielbassa, Marco V Haselager, Danique J C Bax, et al.
Blood Cancer Journal|April 21, 2022
Long-term trends in the loss in expectation of life after a diagnosis of chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2018Lina van der Straten, Carolien C H M Maas, Mark-David Levin, et al.
The Lancet. Oncology|September 18, 2015
Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 studyMarinus H J van Oers, Kazimierz Kuliczkowski, Lukáš Smolej, et al.
Leukemia|January 24, 2020
Validation of the FIRST simplified frailty scale using the ECOG performance status instead of patient-reported activitiesClaudia A M Stege, Bronno van der Holt, Avinash G Dinmohamed, et al.
Journal of Thoracic Imaging|February 26, 2019
Noncontrast Chest Computed Tomographic Imaging of Obesity and the Metabolic Syndrome: Part I Cardiovascular FindingsChristopher L Schlett, Johanna Nattenmüller, Nanae Tsuchiya, et al.
Hemasphere|February 2, 2022
Pomalidomide in Patients With Relapsed and/or Refractory Multiple Myeloma: A Prospective Study Within the Nationwide Netherlands Cancer RegistryRuth Wester, Avinash G Dinmohamed, Bronno van der Holt, et al.
Pharmaceuticals (Basel, Switzerland)|January 13, 2021
The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer PatientsLeni van Doorn, Marie-Rose B S Crombag, Hánah N Rier, et al.
European Journal of Epidemiology|March 22, 2023
Risk of cancer after ST-segment-elevation myocardial infarctionMaarten J G Leening, Nathalie I Bouwer, M Arfan Ikram, et al.
Hemasphere|April 21, 2020
Functional Differences Between EBV- and CMV-Specific CD8<sup>+</sup> T cells Demonstrate Heterogeneity of T cell Dysfunction in CLLTom Hofland, Iris de Weerdt, Sanne Endstra, et al.
Hemasphere|July 11, 2020
Development of a Patient Centered Outcome Set for Patients With Multiple Myeloma to be Used in Clinical PracticeSimone Oerlemans, M Christine Bennink, Mark David Levin, et al.
Pageof 22

Showing results (121-130 of 217) with videos related to

Sort By:
Pageof 22
Leukemia|April 26, 2023
Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translationKaroline Kielbassa, Marco V Haselager, Danique J C Bax, et al.
Blood Cancer Journal|April 21, 2022
Long-term trends in the loss in expectation of life after a diagnosis of chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2018Lina van der Straten, Carolien C H M Maas, Mark-David Levin, et al.
The Lancet. Oncology|September 18, 2015
Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 studyMarinus H J van Oers, Kazimierz Kuliczkowski, Lukáš Smolej, et al.
Leukemia|January 24, 2020
Validation of the FIRST simplified frailty scale using the ECOG performance status instead of patient-reported activitiesClaudia A M Stege, Bronno van der Holt, Avinash G Dinmohamed, et al.
Journal of Thoracic Imaging|February 26, 2019
Noncontrast Chest Computed Tomographic Imaging of Obesity and the Metabolic Syndrome: Part I Cardiovascular FindingsChristopher L Schlett, Johanna Nattenmüller, Nanae Tsuchiya, et al.
Hemasphere|February 2, 2022
Pomalidomide in Patients With Relapsed and/or Refractory Multiple Myeloma: A Prospective Study Within the Nationwide Netherlands Cancer RegistryRuth Wester, Avinash G Dinmohamed, Bronno van der Holt, et al.
Pharmaceuticals (Basel, Switzerland)|January 13, 2021
The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer PatientsLeni van Doorn, Marie-Rose B S Crombag, Hánah N Rier, et al.
European Journal of Epidemiology|March 22, 2023
Risk of cancer after ST-segment-elevation myocardial infarctionMaarten J G Leening, Nathalie I Bouwer, M Arfan Ikram, et al.
Hemasphere|April 21, 2020
Functional Differences Between EBV- and CMV-Specific CD8<sup>+</sup> T cells Demonstrate Heterogeneity of T cell Dysfunction in CLLTom Hofland, Iris de Weerdt, Sanne Endstra, et al.
Hemasphere|July 11, 2020
Development of a Patient Centered Outcome Set for Patients With Multiple Myeloma to be Used in Clinical PracticeSimone Oerlemans, M Christine Bennink, Mark David Levin, et al.
Pageof 22